Chris Tyler

Chris Tyler

InvestorPlace Contributor

Chris Tyler, a Wall Street veteran of more than 20 years, began his career in the financial markets working on the trading floor of the AMEX in New York as an equity option market maker at Interactive Brokers’ floor trading unit Timber Hill LLC.

After moving to San Francisco to make markets on the P-Coast exchange during the dot-com craze and spending nearly a decade working in names like Philip Morris, Seagate and Compaq, Chris hung up his smock and trading badge, but not his passion for options and the markets.

Since exiting the floor, and for the better part of the past dozen years, Chris has worked as an option and market strategist, writing analyses for Trading Markets, Charles Schwab subsidiary Optionetics and as a featured columnist at Investor’s Business Daily.

Aside from offering his trading insights at InvestorPlace.com, Chris is currently studying for his Accredited Portfolio Management Advisor (APMA) designation, manages investments for closely held accounts and offers his services as an investment strategist to GLJ Advisors, a CA based RIA.

Chris, his wife and blue heeler live in the Pacific NW. And if you can’t follow him around in your own VW Vanagon or Westfalia, feel free to follow him on Twitter via @Options_CAT.

Recent Articles

3 IPO Cathie Wood Stocks to Buy

By Chris Tyler, InvestorPlace Contributor

It's time to follow the money in three Cathie Wood stocks, while sticking to the price charts in order to enjoy smarter money investments.

Tesla Stock Is Outperforming the Market and Fellow Tech Giants

By Chris Tyler, InvestorPlace Contributor

There are far few doubters short selling TSLA stock these days, but that's no reason to think it's too late to get in on the action.

Opportunity Knocks in Opendoor Stock Amid 2021’s Numerous Challenges

By Chris Tyler, InvestorPlace Contributor

OPEN stock has been making the best of a challenging red-hot real estate market and those efforts should pay off in the future.

Merck’s Good News Doesn’t End the Bullish Story for Novavax

By Chris Tyler, InvestorPlace Contributor

Investors are pointing fingers at Merck, but a tricky start to October could yet turn into a treat for buyers of NVAX stock

It’s Time To Drop Ocugen Stock While You Still Can

By Chris Tyler, InvestorPlace Contributor

Hope is one thing, but for investors in OCGN stock expecting regulators or other bulls to come to the rescue is looking less likely

3 Most-Shorted Stocks Ready for Buying in October

By Chris Tyler, InvestorPlace Contributor

Bottoms are notorious for a seasonally weak and notorious October, but these most-shorted stocks insist treats for bulls are hear today.

Options for Those Who Feel It’s Time to Finally Buy Jumia

By Chris Tyler, InvestorPlace Contributor

It was a challenging quarter for Jumia, but JMIA stock is showing indications it could be the next big thing in e-commerce.

SmileDirectClub Shares Are Retreating, but There May Be Hope for Bulls

By Chris Tyler, InvestorPlace Contributor

It hasn't worked out for bulls of all stripes in SDC stock this past year, but October could produce some faster money and ear-to-ear grins.

3 Large-Cap Stocks to Sell or Short

By Chris Tyler, InvestorPlace Contributor

If September's bow to market seasonality is any indication, it's time for bulls to be very fearful of this trio of large-cap stocks.

Aterian Clicks With the Short-Squeeze Crowd, But Is Risky

By Chris Tyler, InvestorPlace Contributor

When it comes to ATER stock there's no judgment, but traders should know what they're buying to avoid holding the next Brooklyn Bridge.

Load More